Alestramustine

This article will address Alestramustine from a broad and detailed approach, with the aim of providing the reader with a complete and in-depth vision of this topic. Its origins, evolution and relevance today will be explored, as well as its implications in different areas. Different perspectives, expert opinions and relevant data will be analyzed that will allow the reader to comprehensively understand Alestramustine. In addition, case studies and concrete examples will be presented that will illustrate the importance and impact of Alestramustine in today's society. Through this article, we seek to offer an informed and enriching perspective on Alestramustine, which invites reflection and debate.

Alestramustine
Clinical data
Other namesAlanylestramustine; Estradiol 3-(bis(2-chloroethyl)carbamate) 17β-(L-alaninate); Estradiol 3-(bis(2-chloroethyl)carbamate) 17β-(2β-aminopropanoate); Estradiol 3-(bis(2-chloroethyl)carbamate) 17β-((2S)-2-aminopropanoate)
Drug classChemotherapeutic agent; Estrogen; Estrogen ester
Identifiers
  • -13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopentaphenanthren-17-yl] (2S)-2-aminopropanoate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H36Cl2N2O4
Molar mass511.48 g·mol−1
3D model (JSmol)
  • CC(C(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl)C)N
  • InChI=1S/C26H36Cl2N2O4/c1-16(29)24(31)34-23-8-7-22-21-5-3-17-15-18(33-25(32)30(13-11-27)14-12-28)4-6-19(17)20(21)9-10-26(22,23)2/h4,6,15-16,20-23H,3,5,7-14,29H2,1-2H3/t16-,20+,21+,22-,23-,26-/m0/s1
  • Key:NRUFLTXGIPFVSH-KBVRNWHJSA-N

Alestramustine (INNTooltip International Nonproprietary Name), also known as estradiol 3-(bis(2-chloroethyl)carbamate) 17β-(L-alaninate), is a cytostatic antineoplastic agent which was never marketed.[1][2] It is the L-alanine ester of estramustine, which is a combination of the nitrogen mustard normustine coupled via a carbamate to the estrogen estradiol.[1][3] Alestramustine acts as a prodrug to estramustine, and also forms estradiol as a byproduct.[1][3] The drug, via its active metabolites, binds to microtubule-associated proteins and β-tubulin and interferes with microtubule function, thereby inhibiting cell division.[1][3] Due to its estrogen moiety, alestramustine is selectively concentrated in estrogen receptor-positive cells such as prostate and breast.[1]

See also

References

  1. ^ a b c d e NCI Thesaurus. "Alestramustine". Retrieved 24 June 2016.
  2. ^ Milne GW (1 July 2000). Ashgate Handbook of Antineoplastic Agents. Wiley. p. 5. ISBN 978-0-566-08382-2.
  3. ^ a b c Tripathi KD (30 September 2013). Essentials of Medical Pharmacology. JP Medical Ltd. pp. 866–. ISBN 978-93-5025-937-5.



Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about a steroid is a stub. You can help Wikipedia by expanding it.